The immunomodulatory activity of bone-marrow-derived CD362+ human MSCs in vitro and in vivo has been previously reported in a relevant model of E. coli pneumonia, decreasing pneumonia severity and improving recovery after ventilation injury [14]. This evidence concerns the gene SDC2 and pneumonia.